CV Sciences, Inc. Provides Revenue Guidance for the First Quarter of Fiscal 2020
March 16, 2020 at 08:05 pm
Share
CV Sciences, Inc. provided revenue guidance for the first quarter of fiscal 2020. For the first quarter of fiscal 2020, the company expects revenue to be in the range of $6 million to $8 million.
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
CV SCIENCES, INC. 
